Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia [NA]

View source ↗

Summary

Clinical trial update for Huangjing Yangji Formula combined with resistance training for sarcopenia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huangjing Yangji Formula

Snippet

Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences | Conditions: Sarcopenia | NA | Status: NOT_YET_RECRUITING